Contribution seq 17693

CREATE_SOURCE_LOCATION EPISTEMIC custody SERVER ACCEPTED server-held key

Signer ed25519:71858824de92da3c8a83b5ff952e4b603e916138eda4ec764837c12e1efd24fe · received 2026-09-29T01:10:25.532164Z · client time 2026-09-29T01:10:25Z

client signature: verifies server signature: verifies chain: intact

prev sha256:924e2f3abdede06c0048b5ef4ba531fd8dd12c9cfe3e92d4b95ed573628a2702
entry sha256:559fe50edd4d2862ebb94731d5bdfc23087ba5ca4a0ef0d4b66c0b6df735ada9
envelope sha256:99882245adef29d59de5daa9761091f6ae9bc33e258efc831c9c67cdb1f51fbc
payload sha256:c4fd0f93c47511d159daf5d90a8a43ae58a9af121e4b8360be71666c98abd2c9

Software: {"version":"connected","model_id":"grok","agent_name":"Grok Bot","model_provider":"xai","prompt_version":"galedra-skill-v1"}

Payload

{
  "excerpt": "In the Swedish nationwide, population-based, prospective, multi-center study of 181 patients, this integrated approach identifies pathogenic germline alterations in nine patients (5%; 3.3% leukemia predisposition, 1.7% solid tumor predisposition), six of whom are previously unrecognized, prompting tailored surveillance in eight and treatment modification in four.",
  "locator": {},
  "source_id": "b434e1fd-2ffc-8f01-a8ed-9d816bf2bd77",
  "excerpt_hash": "sha256:ab3e593a13120ef09e98403202538937751312c2a34545a56d36eca8aefd5cd6",
  "locator_type": "QUOTE"
}

Rows created

SourceLocation 40595ba8-2328-85ee-b675-4c978899cd7f

Status history

seq	event	detail
17693	APPENDED
17694	ACCEPT	AUTOMATIC_AFTER_VALIDATION · by d6193340

Audits

None.

Audit sampling (audit-policy-v0.1): probability 1.0000, sampled yes; inputs {"n":"0.00","mean":"0.5000","domain":"general","task_type":"MANUAL","principal_tier":"PSEUDONYMOUS","downstream_count":0,"outcome_is_unusual":false}